Literature DB >> 20042411

Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis.

Russel J Reiter1, Dan Xian Tan, Thomas C Erren, Lorena Fuentes-Broto, Sergio D Paredes.   

Abstract

In industrialized countries, certain types of cancer, most notably, breast and prostate, are more frequent than in poorly developed nations. This high cancer frequency is not explained by any of the conventional causes. Within the past decade, numerous reports have appeared that link light at night with an elevated cancer risk. The three major consequences of light at night are sleep deprivation, chronodisruption, and melatonin suppression. Each of these individually or in combination may contribute to the reported rise in certain types of cancer. In this article, the potential mechanisms underlying the basis of the elevated cancer risk are briefly discussed. Finally, if cancer is a consequence of excessive nighttime light, it is likely that other diseases/conditions may also be exaggerated by the widespread use of light after darkness onset.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042411     DOI: 10.1177/1534735409352026

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  17 in total

1.  Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore.

Authors:  Anna H Wu; Frank Z Stanczyk; Renwei Wang; Woon-Puay Koh; Jian-Min Yuan; Mimi C Yu
Journal:  Int J Cancer       Date:  2012-06-28       Impact factor: 7.396

Review 2.  Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind.

Authors:  Jonathan S Emens; Charmane I Eastman
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 3.  Shift work and cancer: the evidence and the challenge.

Authors:  Thomas C Erren; Puran Falaturi; Peter Morfeld; Peter Knauth; Russel J Reiter; Claus Piekarski
Journal:  Dtsch Arztebl Int       Date:  2010-09-24       Impact factor: 5.594

4.  Melatonin inhibits the expression of vascular endothelial growth factor in pancreatic cancer cells.

Authors:  Dong Lv; Pei-Lin Cui; Shi-Wei Yao; You-Qing Xu; Zhao-Xu Yang
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

5.  Shift Work and Prostate Cancer Incidence in Industrial Workers: A Historical Cohort Study in a German Chemical Company.

Authors:  Gaël P Hammer; Katharina Emrich; Michael Nasterlack; Maria Blettner; Mei Yong
Journal:  Dtsch Arztebl Int       Date:  2015-07-06       Impact factor: 5.594

Review 6.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

7.  Night shift work and levels of 6-sulfatoxymelatonin and cortisol in men.

Authors:  Dana K Mirick; Parveen Bhatti; Chu Chen; Frank Nordt; Frank Z Stanczyk; Scott Davis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-05       Impact factor: 4.254

8.  Neurotoxins: free radical mechanisms and melatonin protection.

Authors:  Russel J Reiter; Lucien C Manchester; Dun-Xian Tan
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

9.  Scientific basis for the potential use of melatonin in bone diseases: osteoporosis and adolescent idiopathic scoliosis.

Authors:  E J Sánchez-Barceló; M D Mediavilla; D X Tan; R J Reiter
Journal:  J Osteoporos       Date:  2010-06-01

10.  Impact of lifestyle and technology developments on sleep.

Authors:  Tamar Shochat
Journal:  Nat Sci Sleep       Date:  2012-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.